Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Technical Advisory Board Enhanced

9 Jan 2013 07:00

RNS Number : 1103V
Oxford Advanced Surfaces Group PLC
09 January 2013
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

Technical Advisory Board Enhanced

 

Oxford Advanced Surfaces Group ("OAS") the AIM listed technology developer targeting a number of global markets including consumer and industrial displays, solar panels, eyewear and the electronics and adhesion markets, has today announced a key addition to its Technical Advisory Board ("TAB").

 

From 1 January 2013, Professor Steven Abbott joined Professor Mark Moloney on the OAS TAB. Steven brings with him a wealth of industrial, scientific and commercial knowledge from both research posts and a long commercial career at ICI and MacDermid Autotype, covering all areas of the OAS target markets. He is a Fellow of the Royal Society of Chemistry and an independent consultant to global tier 1 industrial partners.

 

Adrian Meldrum, CEO said:

 

 "We are delighted to welcome Steven to the Advisory Board. He has many years of invaluable experience in the key industries and applications in which we operate and will add significant value to our technical and commercial discussions with prospective users of our technology."

 

Prof Steven Abbott commented:

 

 "I am very excited by the opportunity to work with OAS. Its technology offers a range of innovative solutions to significant problems in the world of manufacturing.."

 

 

Prof Steven Abbott received his Oxford Chemistry D Phil for work carried out at Harvard. His post-doctoral was in the Nobel Prizewinning lab of Jean-Marie Lehn at Strasbourg. He is Visiting Professor at the School of Engineering at the University of Leeds. He has worked many years in the high-tech coating industry and along the way developed a passion for computer models that could give real-world insight to complex scientific issues such as precision coating or polymer/nanoparticle solubilities. He is an independent consultant at Steven Abbott TCNF Ltd where he continues to develop software apps on solubility, surfactancy, adhesion, diffusion and advises internationally on topics as diverse as cosmetic/pharma skin delivery, organic photovoltaics, packaging films and "green" surfactant design.

 

09 January 2013

Enquiries:

 

Oxford Advances Surfaces Group Plc www.oxfordsurfaces.com

Adrian Meldrum, Chief Executive Officer

Philip Spinks, Chief Financial Officer T: 01865 854 807

 

W H Ireland Limited www.wh-ireland.co.uk

John Wakefield / Marc Davies T: 0117 945 3471

 

Lothbury FS Ltd www.lothburyfs.com

Gary Middleton / Michael Padley T: 0203 440 7620

 

 

Editors' Note

 

Oxford Advanced Surfaces Group plc (OAS) is a research-based company that develops and licenses intellectual property and products in the areas of highly reactive chemistry and anti-reflective coatings. The Company's research scientists develop innovative solutions in advanced materials and nano-technology for partners to exploit. The Company's solutions apply to real-world, practical processing and innovation challenges as novel polymer and organic materials are introduced to improve cost, weight, space and performance in new products. Initial applications include advanced adhesion, anti-reflective coatings and particle delivery in markets including conventional and plastic electronics, optics, displays, batteries and solar.

www.oxfordsurfaces.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKFDKOBKDDDK
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.